trial

Baduanjin on Patients With Schizophrenia

NCTId NCT04430309
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 48 (actual)
Sponsored by Chang Gung Memorial Hospital
Primary completion 2022-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
48 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-04-10
Primary completion
2022-06-30
Eligibility
ALL · 40 Years

Interventions & indications

Drugs
Baduanjin exercise programBrisk walking program

Sponsors

Chang Gung Memorial HospitalLead Sponsor
National Taiwan University HospitalCollaborator

Sites

1 total
Kaohsiung City, Taiwan

Facts & assertions

4 sourced
Enrollment
48
Phase
NA
Primary Completion Date
2022-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Baduanjin exercise program
drug
Brisk walking program
drug
lead_sponsor
Chang Gung Memorial Hospital
company
collaborator
National Taiwan University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication